COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation
19/07/2018
Acquisition expands Emerald’s business to analytical testing services and import/export opportunities facilitated by dealer license VICTORIA, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
19/07/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies: Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
19/07/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Capital Senior Living Corporation Announces Release Date for Second Quarter 2018 Financial Results
19/07/2018
DALLAS, July 19, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s second quarter 2018 financial results. The call will be [...]
OraSure Technologies Earnings Conference Call Invitation
19/07/2018
2018 Second Quarter Earnings Conference Call Wednesday, August 8, 2018, 5:00 p.m. ET BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings [...]
Vical Announces Review of Potential Strategic Transactions
19/07/2018
SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that its Board of Directors plans to explore a range of strategic options to enhance shareholder value. The company has [...]
Medigus Announces Pricing of $10 Million Underwritten Public Offering
19/07/2018
OMER, Israel, July 19, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct [...]
PotNetwork Holdings, Inc. Retains Major Law Firms For Guidance on Intellectual Property and FDA Product Registrations
19/07/2018
FT LAUDERDALE, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announces today that the company has engaged national law firms in Fort Lauderdale, Florida and [...]
HealthLynked Corp. Announces Closing of $2,000,000 Private Placement
19/07/2018
NAPLES, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK), announced today that it has closed a $2,000,000 private placement of common stock and warrants with an institutional investor. [...]
Solon Eiendom ASA :Primary insider notification
19/07/2018
(Oslo, Norway, July 18, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 25.000 shares in Solon Eiendom ASA at a price of NOK 27,911 per share. [...]
Sales Of Olainfarm In Six Months Increase By 5%. The Fastest Growth Recorded In Japan And Belarus
19/07/2018
Olaine, June 18, 2018 Sales Of Olainfarm In Six Months Increase By 5%. The Fastest Growth Recorded In Japan And Belarus Consolidated Results of June and 6 months of 2018 Preliminary consolidated Olainfarm Group sales in [...]
Shire plc : Rule 2.9 Announcement
19/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 July 2018 Shire [...]
MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner
19/07/2018
Exclusive global license agreement with Novartis on MOR106 MOR106, a monoclonal antibody directed against IL-17C, will be developed further in atopic dermatitis (AtD) and potentially other indications Up-front payment [...]
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
19/07/2018
Basel, Switzerland, July 19, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has received a CHF 2 million milestone payment from its partner Grupo Biotoscana S.L. ("GBT"), based on the first [...]
Novartis demonstrates commitment to lead immuno-dermatology by in-licensing IL-17C compound for atopic dermatitis
19/07/2018
Novartis enters an exclusive license agreement with Galapagos and MorphoSys for an investigational biologic compound, MOR106, a novel antibody directed against IL-17C IL-17C is believed to contribute significantly to [...]
Evolus, Inc. Announces Pricing of Public Offering of Common Stock
19/07/2018
IRVINE, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today the pricing of its public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per [...]
Establishment Labs Announces Pricing of Initial Public Offering
19/07/2018
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing [...]
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
19/07/2018
STAMFORD, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares
19/07/2018
Lausanne, Switzerland, July 19, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the price per common share of USD 11.75 [...]

Pages